BCRX

BioCryst Pharmaceuticals Inc

6.67

USD

BCRX Earnings Reports

Positive Surprise Ratio

BCRX beat 22 of 40 last estimates.

55%

Next Report

Date of Next Report

Feb 25, 2026

Estimate for Q4 25 (Revenue/ EPS)

$154.35M

$0.04

Implied change from Q3 25 (Revenue/ EPS)

-3.16%

-33.33%

Implied change from Q4 24 (Revenue/ EPS)

+17.35%

-130.77%

BioCryst Pharmaceuticals Inc earnings per share and revenue

On Nov 03, 2025, BCRX reported earnings of 0.06 USD per share (EPS) for Q3 25, beating the estimate of 0.03 USD, resulting in a 67.13% surprise. Revenue reached 159.40 million, compared to an expected 166.23 million, with a -4.11% difference. The market reacted with a -6.28% price change (close before vs. close after earnings).

Looking ahead to Q4 25, 13 analysts forecast an EPS of 0.04 USD, with revenue projected to reach 154.35 million USD, implying an decrease of -33.33% EPS, and decrease of -3.16% in Revenue from the last quarter.

FAQ

What were BioCryst Pharmaceuticals Inc's earnings and revenue for the latest quarter Q3 2025?

For Q3 2025, BioCryst Pharmaceuticals Inc reported EPS of $0.06, beating estimates by 67.13%, and revenue of $159.40M, -4.11% below expectations.

How did the market react to BioCryst Pharmaceuticals Inc's Q3 2025 earnings?

The stock price moved down -6.28%, changed from $7.32 before the earnings release to $6.86 the day after.

When is BioCryst Pharmaceuticals Inc expected to report next?

The next earning report is scheduled for Feb 25, 2026.

What are the forecasts for BioCryst Pharmaceuticals Inc's next earnings report?

Based on 13 analysts, BioCryst Pharmaceuticals Inc is expected to report EPS of $0.04 and revenue of $154.35M for Q4 2025.

Which companies are reporting earnings today?

Check FXEmpire's Earnings Calendar for today's list of reporting companies.